Search results
Results from the WOW.Com Content Network
Endo Pharmaceuticals at various times was a significant funder of the American Pain Foundation, which has been accused of producing misleading and biased materials relating to opiod prescribing. [ 52 ] [ 53 ] APF shut down in 2012 after the United States Senate Committee on Finance began an investigation into the relationships between narcotic ...
Endo Pharmaceuticals (ENDP) agreed to buy generics company Qualitest Pharmaceuticals for $1.2 billion cash. Qualitest is the sixth-largest U.S. generics company as measured by prescriptions filled.
Founded in 1919 as a maker of digitalis drugs, [3] Upsher-Smith has traditionally focused on the manufacture of generic medications.. In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, to Sawai Group Holdings Co., Ltd. [], a large publicly traded generics company in Japan that had been seeking entry into the U.S. market. [4]
This page was last edited on 5 September 2024, at 13:29 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. Shares of newly public AMRX began trading on the NYSE on May 7, 2018. [9] Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism. [10]
Bayer AG began marketing in the United States soon after the company's inception in Germany. In the late 19th century, they began to sell their trademark medication, aspirin . While the name "aspirin" became synonymous with Bayer for over a quarter of a century, the company's patents and trademarks were seized by the United States Office of ...
Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.
New England Compounding Center (NECC) is a compounding pharmacy founded in 1998, along with its sister companies Ameridose, Medical Sales Management Inc, and Alaunus Pharmaceutical LLC. Based in Framingham, Massachusetts , the New England Compounding Center was founded by brothers-in-law Greg Conigliaro and Barry Cadden.